Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2021/3619131 http://scihub22266oqcxt.onion/10.1155/2021/3619131 34055430!8123983!34055430     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Case+Rep+Infect+Dis 2021 ; 2021 (ä): 3619131 Nephropedia Template TP {{tp|p=34055430|t=2021. Exacerbating Guillain-Barre Syndrome Eight Days after Vector-Based COVID-19 Vaccination |pdf=|usr=}}{{34055430}} gab.com Text Exacerbating Guillain-Barre Syndrome Eight Days after Vector-Based COVID-19 Vaccination JO: Case Rep Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=34055430 #FOAvip Since the introduction of mRNA technology-based and vector-based COVID-19 vaccines, adverse reactions to these agents have been occasionally reported. Exacerbation of Guillain-Barre syndrome (GBS) shortly after COVID-19 vaccination has not been communicated. The patient is a 32-year-old male who developed progressive sensory disturbances and muscle weakness 8 days after the first dosage of a vector-based vaccine. Cerebrospinal fluid investigations revealed a dissociation cyto-albuminque, and nerve conduction studies revealed demyelination. Intravenous immunoglobulin (IVIG) exhibited only a marginal effect for both sensory and motor deficits. The patient's history was moreover positive for previous GBS with marked motor deficits 14 years earlier, which responded favourably to IVIG leading to almost complete recovery within 9 months of rehabilitation. Although apparently extremely rare, neurologists should remain vigilant for a potential recurrence of GBS after vaccination with a vector-based COVID-19 vaccine. Twit Text FOAVip Exacerbating Guillain-Barre Syndrome Eight Days after Vector-Based COVID-19 Vaccination ????Case Rep Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=34055430 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34055430 #FOAvip English Wikipedia <ref>{{Cite pmid|34055430}}</ref> Exacerbating Guillain-Barre Syndrome Eight Days after Vector-Based COVID-19 Vaccination #MMPMID34055430 Finsterer J Case Rep Infect Dis 2021[]; 2021 (ä): 3619131 PMID34055430show ga Since the introduction of mRNA technology-based and vector-based COVID-19 vaccines, adverse reactions to these agents have been occasionally reported. Exacerbation of Guillain-Barre syndrome (GBS) shortly after COVID-19 vaccination has not been communicated. The patient is a 32-year-old male who developed progressive sensory disturbances and muscle weakness 8 days after the first dosage of a vector-based vaccine. Cerebrospinal fluid investigations revealed a dissociation cyto-albuminque, and nerve conduction studies revealed demyelination. Intravenous immunoglobulin (IVIG) exhibited only a marginal effect for both sensory and motor deficits. The patient's history was moreover positive for previous GBS with marked motor deficits 14 years earlier, which responded favourably to IVIG leading to almost complete recovery within 9 months of rehabilitation. Although apparently extremely rare, neurologists should remain vigilant for a potential recurrence of GBS after vaccination with a vector-based COVID-19 vaccine. äExacerbating Guillain-Barre Syndrome Eight Days after Vector-Based COV(epmc).pdf DeepDyve Pubget Overpricing